| Serial Number | 87229065 |
| Word Mark | INZERDIA |
| Filing Date | Monday, November 7, 2016 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Tuesday, June 30, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 25, 2017 |
| Goods and Services | Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 10, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Allergan Sales, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Irvine, CA 92612 |
| Party Name | Allergan Sales, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Irvine, CA 92612 |
| Event Date | Event Description |
| Tuesday, June 30, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, June 30, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, December 6, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 5, 2019 | EXTENSION 5 GRANTED |
| Tuesday, December 3, 2019 | EXTENSION 5 FILED |
| Thursday, December 5, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, December 3, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, March 19, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 15, 2019 | EXTENSION 4 GRANTED |
| Friday, March 15, 2019 | EXTENSION 4 FILED |
| Friday, March 15, 2019 | TEAS EXTENSION RECEIVED |
| Saturday, November 3, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 1, 2018 | EXTENSION 3 GRANTED |
| Thursday, November 1, 2018 | EXTENSION 3 FILED |
| Thursday, November 1, 2018 | TEAS EXTENSION RECEIVED |
| Wednesday, June 13, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, June 11, 2018 | EXTENSION 2 GRANTED |
| Monday, June 11, 2018 | EXTENSION 2 FILED |
| Monday, June 11, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, October 31, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 27, 2017 | EXTENSION 1 GRANTED |
| Friday, October 27, 2017 | EXTENSION 1 FILED |
| Friday, October 27, 2017 | TEAS EXTENSION RECEIVED |
| Wednesday, June 21, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 25, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 25, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 5, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, March 17, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, March 2, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 1, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 1, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 20, 2017 | ASSIGNED TO LIE |
| Tuesday, February 7, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 7, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 7, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 7, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 7, 2017 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, February 7, 2017 | WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST |
| Sunday, January 22, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, December 31, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 30, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 30, 2016 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, December 22, 2016 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, December 22, 2016 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 22, 2016 | SUSPENSION LETTER WRITTEN |
| Wednesday, December 21, 2016 | ASSIGNED TO EXAMINER |
| Thursday, November 10, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, November 10, 2016 | NEW APPLICATION ENTERED IN TRAM |